Search results

Page results

• Sarah, Duchess of York and Their Royal Highnesses Princesses Beatrice and Eugenie meet young people with cancer at UCLH

  In a joint public appearance, the trio, who are Honorary Patrons of Teenage Cancer Trust, visited the ward to meet young patients and thank staff for their work.

• UCLH patient thanks amazing staff after recovering from COVID-19

  One of our patients who is recovering from COVID-19 has been appearing across national media as she recounts her story and thanks the staff who saved her life.

• New surgical technique preserves continence in men after prostate removal

  A new surgical technique could remove the risk of urinary incontinence after surgery to remove the prostate for men with prostate cancer.

• UCLH coordinates cancer care for north and east London patients during the COVID-19 pandemic

  UCLH is managing one of the three cancer hubs across London, so that during the COVID-19 coronavirus pandemic cancer surgery is available for patients with the most immediate needs.

• Brain cancer patient doing well after world-first immunotherapy treatment

  UCLH has treated the first brain cancer patient with immunotherapy prior to standard treatment as part of a pioneering trial.

• Launch of new services to support patients with sickle cell disease, thalassaemia, and other inherited red cell disorders

  The North Central London Integrated Care System (NCL ICS) has new services and staff training to support patients with inherited red cell disorders, including Sickle Cell and Thalassaemia, living in Barnet, Camden, Enfield, Haringey and Islington.

• Prostate cancer

  UCLH is the London Cancer Centre for the surgical treatment of prostate cancer.

• Inflammatory Bowel Disease and Pregnancy

  This page provides information for pregnant women with Inflammatory Bowel Disease.

• Palliative care

  The palliative care team at UCLH provides specialist palliative and end-of-life care to any patient who has a life-limiting illness, and offers support to families and carers.

• Study reveals limitations of drug proposed for lung cancer treatment

  Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.